Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Capricor Therapeutics Inc have a median target of 30.00, with a high estimate of 77.00 and a low estimate of 25.00. The median estimate represents a 65.75% increase from the last price of 18.10.
High | 325.4% | 77.00 |
Med | 65.7% | 30.00 |
Low | 38.1% | 25.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 13, 2024.
Average growth rate | -339.28% |
Average growth rate | +13.11% |
More ▼
Revenue history & estimates in USD
Average growth rate | +18.71% |
Average growth rate | +435.51% |
More ▼